BI-1388

Overview

BI-1388 is a macrocyclic acylsulfonamide-based HCV NS3-4A protease inhibitor. BI-1388 inhibits clinically relevant drug-resistant mutant strains ( KRAS D168V gt 1b and KRAS R155K gt 1a ) and exhibits high liver distribution. BI-1388 is applicable for the research of HCV infection .

Application

Products | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > HCV Protease | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Infection | Products > Signaling Pathways > HCV | Products > Signaling Pathways > HCV Protease | Products > Signaling Pathways > Ras

Product Information

• Catalog No.: HY-115516
• CAS No.: 1309952-03-1
• Molecular Formula: C41H53N7O9S
• Molecular Weight: 819.97
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source